Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indinavir, Ritonavir and Fosamprenavir PK in HIV
NCT00148785Phase 4Completed
- Sponsor
- Emory University
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fosamprenavir in human immunodeficiency virus infection (HIV), sponsored by Emory University. Primary endpoint: Peak concentration at 12 hours. Started Jul 2005; status: completed.
02
Drugs
fosamprenavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00148785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00148785.